MAPT and Alzheimer disease: Interestingly, from our analysis, CSF SIRT2 positively correlated with CSF p-tau levels (ρ = 0.48, p < 0.005) in AD-MCI patients, thus supporting the evidence of a possible association between SIRT2 activity and tau pathology.